Skip to content
Screener

Aktis Oncology, Inc. AKTS Q2 2026 earnings

Reported August 13, 2026 · After market close

Revenue$3.4MBeat by $686.3K
EPS-$0.44Miss by $0.01
Revenue estimate$2.7M
EPS estimate-$0.43

Next report

Date not yet announced

FAQ

When did Aktis Oncology, Inc. report Q2 2026 earnings?
Aktis Oncology, Inc. (AKTS) reported Q2 2026 earnings on August 13, 2026 after market close.
What were Aktis Oncology, Inc.'s Q2 2026 revenue and EPS?
Aktis Oncology, Inc. reported revenue of $3.4M and eps of $-0.44 for Q2 2026.
Did Aktis Oncology, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $2.7M by $686.3K. EPS missed the consensus estimate of $-0.43 by $0.01.
Where can I find Aktis Oncology, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-349133) and the 10-Q periodic report (0001193125-26-349144) directly on SEC EDGAR. The filing index links above go to sec.gov.